ReviewHypertension research : official journal of the Japanese Society of Hypertension2025
Improving adherence in hypertension management: digital tools, barriers, and innovations across Asia.
Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Application of digital health technologies in hypertension self-management: a narrative review.Frontiers in public health · 2026Review
- Digital Health Delivery Models for Hypertension Self-Care in Asia: A Systematic Review.Journal of multidisciplinary healthcare · 2026Review
- Mapping Clinical Intent in Internet Hospitals: Identifying and Profiling Patient Demand via Natural Language Processing.Computational and structural biotechnology journal · 2026Article
- Development and evaluation of an IoT-based hypertension surveillance system in community health settings: a mixed-methods quasi-experimental study protocol.BMC health services research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Asian countries are rapidly embracing digital technologies amid rising hypertension prevalence and aging populations. While digital tools like mobile apps, telehealth reminders, and AI-driven interventions have shown global success in managing hypertension, their adoption in Asia remains limited due to cultural dietary habits, disparities in digital literacy and access, and fragmented healthcare infrastructure present unique barriers to equitable implementation. This mini review examines key challenges and opportunities in applying digital health interventions to improve hypertension adherence in the region. We identify five critical barriers: (1) difficulty in monitoring dietary sodium intake due to limited practical tools and regional dietary diversity, (2) low digital engagement among older adults, who are disproportionately affected by hypertension, (3) lack of interoperability between digital platforms and healthcare systems, (4) a fragmented regulatory landscape that hinders consistent oversight and adoption, and (5) challenges in sustaining long-term user engagement. Achieving meaningful impact will require cross-sector collaboration to standardize data protocols, improve regulatory alignment, ensure affordability, and support user-centered design. As evidence for outcome-based effectiveness grows, digital tools can be integrated into national strategies to reduce cardiovascular disease risk and healthcare costs. Tailoring these technologies to the needs of Asian populations is essential to achieving equitable, sustainable hypertension care and fostering long-term public health resilience across the region.
Indexed as
Identifiers
40374956What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.